RNA EPS Estimates
Atrium Therapeutics, Inc.
$8.34
+$0.02(+0.24%)
19
Overall
--
Value
20
Tech
18
Quality
Market Cap
$142.66M
Volume
108.19K
52W Range
$7.49 - $16.77
Target Price
$22.00
RNA EPS estimates: the consensus estimate for Atrium Therapeutics, Inc.'s current fiscal year is -$4.45 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RNA EPS Estimates
- EPS estimate, current quarter
- $-1.14
- EPS estimate, next quarter
- $-1.57
- EPS estimate, current year
- $-4.45
- EPS estimate, next year
- $-6.69
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNA | $8.34 | +0.2% | 108.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atrium Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW